Postponement of the Syva Award Decision 2020.
![](https://syva.es/wp-content/uploads/2021/01/Premio-Syva-Site-web-visuel-page-2.png)
The decision on the winning doctoral thesis is postponed because of Covid-19.
On 22nd February, the period for presenting doctoral theses defended during the 2018-2019 academic year, and that will compete for the 23rd Syva Award for the best doctoral thesis in animal health, ended.
For this call, a decision on the winning doctoral thesis was scheduled to be made public before 13th April 2020.
Because of the Covid-19 health emergency it will not be possible to publish the decision on the scheduled date. The meetings set by the selection board appointed to evaluate the theses presented have been postponed. This situation also means the date of presenting the award has to be pushed back.
We will keep you updated on dates for the decision and presentation of the Syva Award 2020 when it is possible to schedule them again.
You may also be interested in
![](https://syva.es/wp-content/uploads/2025/01/Vacas-en-granjas-Paises-Bajos-copyrights-Syva-2024-823x462.png)
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.
![](https://syva.es/wp-content/uploads/2025/01/Intro-del-video-explicativo-2-823x462.png)
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...
![](https://syva.es/wp-content/uploads/2025/01/Syvazul-BTV3-Opinion-Positiva-CVMP-EMA--823x462.png)
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.